8-K: Semler Scientific Reports Strong 2024 Financial Results Driven by Bitcoin Strategy

Semler Scientific announces its Q4 and full-year 2024 financial results, highlighting a 107% BTC Yield since July 1, 2024, and total bitcoin holdings of 3,192.

Summary

• Semler Scientific reported its financial results for the fourth quarter and year ended December 31, 2024.
• The company's main use of cash is to acquire and hold bitcoin.
• Semler Scientific has acquired 3,192 bitcoins, valued at approximately $300 million.
• Since launching the bitcoin strategy in May 2024, the company's market capitalization has increased more than 200%.
• The company's BTC Yield was 107% for the year ended December 31, 2024.
• As of December 31, 2024, Semler Scientific held 2,298 bitcoins with a fair value of $214.6 million.
• During 2024, the company purchased 2,298 bitcoins for $189.7 million.
• Through February 14, 2025, an additional 894 bitcoins were purchased for $90.7 million.
• Revenues for 2024 were $56.3 million, a decrease of 17% compared to $68.2 million in 2023.
• Net income for 2024 was $40.9 million, or $5.66 per basic share and $5.13 per diluted share, an increase of 99% compared to $20.6 million in 2023.
• For the fourth quarter of 2024, revenues were $12.4 million, an 18% decrease compared to $15.1 million in 2023.
• Net income for Q4 2024 was $29.2 million, or $3.64 per basic share and $3.41 per diluted share, a 592% increase compared to $4.2 million in Q4 2023.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the significant increase in net income and market capitalization driven by the bitcoin strategy, despite a decrease in revenue. The management's confidence in Bitcoin's long-term potential also contributes to the positive outlook.

Positives

• The company's bitcoin treasury strategy has significantly increased its market capitalization.
• Net income for both the full year and fourth quarter of 2024 showed substantial increases.
• The company successfully raised capital through an ATM offering and convertible notes.
• Income from operations was $20.9 million for the full year 2024.
• Pre-tax income increased 99% to $47.9 million for the full year 2024.
• The company reported an unrealized gain from the change in fair value of Semler Scientifics bitcoin holdings of $24.9 million for the full year 2024.
• The company reported an unrealized gain from the change in fair value of Semler Scientifics bitcoin holdings of $28.8 million for the fourth quarter 2024.

Negatives

• Revenues for both the full year and fourth quarter of 2024 decreased compared to the corresponding periods in 2023.
• Two largest customers comprised 43% and 28% of full year revenues in 2024, respectively, indicating customer concentration risk.

Risks

• The company faces risks inherent with investing in bitcoin, including bitcoin's volatility.
• There is a risk that insurance plans and other customers will not continue to license its cardiovascular testing products.
• Changes in the reimbursement landscape for its customers, including related to CMS rates, pose a risk.
• The company faces the risk of not obtaining a new 510(k) clearance for expanded indications for QuantaFlo.

Future Outlook

Semler Scientific remains committed to significantly expanding its bitcoin holdings and is seeking a new 510(k) clearance for QuantaFlo with expanded indications.

Management Comments

• We are again pleased to report strong performance from our healthcare business with income from operations of $20.9 million for the full year 2024, said Doug Murphy-Chutorian, MD, chief executive officer of Semler Scientific.
• While we continue to support innovation and growth in our healthcare business, our main use of cash is to acquire and hold bitcoin.
• 2024 was a transformative year for Semler Scientific as we embraced a bitcoin treasury strategy to maximize stockholder value, said Eric Semler, chairman of Semler Scientific.
• Through a disciplined and accretive approach, we have acquired 3,192 bitcoins, which are now valued at approximately $300 million.
• We have unwavering confidence in bitcoins long-term potential and view it as digital gold.
• With this conviction, we remain committed to significantly expanding our bitcoin holdings.

Industry Context

The move to adopt Bitcoin as a primary treasury asset is a novel strategy, with few direct comparables in the healthcare technology space. Other companies in different sectors, such as MicroStrategy and Tesla, have also invested in Bitcoin as a treasury asset, but the long-term implications and industry-wide adoption remain uncertain.

Comparison to Industry Standards

• Comparing Semler Scientific's financial performance to other healthcare technology companies is challenging due to its unique bitcoin treasury strategy.
• Traditional metrics like revenue growth and profitability are still relevant, but the impact of bitcoin holdings on the balance sheet and income statement adds a layer of complexity.
• MicroStrategy, a software company, is a notable example of a public company with a significant bitcoin treasury strategy, but its business model differs substantially from Semler Scientific's healthcare focus.
• Tesla's investment in Bitcoin also provides a point of comparison, but its core business is in the automotive industry.

Stakeholder Impact

• Shareholders have benefited from the increase in market capitalization due to the bitcoin strategy.
• The company's employees are impacted by the strategic shift towards bitcoin.
• Customers may be affected by the company's focus on bitcoin, potentially impacting investment in the healthcare business.
• The company's suppliers and creditors are indirectly impacted by the company's financial performance and strategic decisions.

Next Steps

• Semler Scientific will host a conference call today at 4:30 p.m. ET to discuss the results and provide a business update.
• The company will continue to acquire and hold bitcoin.
• Semler Scientific is seeking a new 510(k) clearance for QuantaFlo with expanded indications.

Key Dates